Meets primary objective but not secondary objective [Study As­sess­ment]

posted by Achievwin – US, 2020-03-31 21:09  – Posting: # 21310
Views: 469

As far as Bioequivalence study is concerned there is only a primary objective (no secondary objectives) which is specified in the published BE guidance (in case of FDA), BE acceptance criteria is specified by Regulatory bodies per product. In the absence of a published guidance use the following criteria

1. Fasted and Fed studies
2. BE criteria must be met for 1) Parent drug (unless is not detected) and major circulating active metabolite (it needs to be more than 20% of the parent drug or so),
3. establishing BE for inactive metabolites if they are not major circulating metabolites is only a supportive data)

Hope this helps.

Complete thread:

 Admin contact
20,647 posts in 4,328 threads, 1,436 registered users;
online 18 (0 registered, 18 guests [including 16 identified bots]).
Forum time: 13:50 CEST (Europe/Vienna)

A little Learning is a dang’rous Thing;
Drink deep, or taste not the Pierian Spring:
There shallow Draughts intoxicate the Brain,
And drinking largely sobers us again.    Alexander Pope

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz